Innovate Pharmaceuticals Ltd

Start Date End Date Funded Value Relevance

CSV

25 50 100

£334,194

Sep 12 - Sep 15

IDENTIFICATION OF NUCLEAR PATHWAYS THAT ARE CAUSALLY INVOLVED IN NUCLEOLAR TARGETING OF NF-KAPPAB/RELA.

MRC award to University of Edinburgh and Lesley Stark

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}